Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Maruff

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention TrialK V Papp, D M Rentz, P Maruff, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Neurology|May 16, 2007
Imaging beta-amyloid burden in aging and dementiaC C Rowe, S Ng, U Ackermann, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
The Journal of Prevention of Alzheimer'S Disease|December 18, 2020
The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention TrialK V Papp, D M Rentz, P Maruff, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Neurology|May 16, 2007
Imaging beta-amyloid burden in aging and dementiaC C Rowe, S Ng, U Ackermann, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's ContinuumA Feizpour, V Doré, J D Doecke, et al.
Pageof 11